NIM
RCKT icon

NEOS Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

NEOS Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,030
Closed -$78.5K – 647
2025
Q2 		$78.5K Sell
32,030
-4,833
-13% -$24.5K ﹤0.01% 614
2025
Q1 		$246K Sell
36,863
-54,122
-59% -$535K ﹤0.01% 572
2024
Q4 		$1.14M Sell
90,985
-20,469
-18% -$308K 0.03% 382
2024
Q3 		$2.06M Buy
111,454
+8,607
+8% +$176K 0.06% 258
2024
Q2 		$2.21M Buy
102,847
+45,247
+79% +$1.04M 0.09% 201
2024
Q1 		$1.55M Buy
57,600
+38,080
+195% +$1.08M 0.1% 197
2023
Q4 		$585K Buy
+19,520
New +$431K 0.06% 254

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

NEOS Investment Management's RCKT Position: Q3 2025 in Review

NEOS Investment Management sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 32,030 shares — an estimated $78.5K sold.

NEOS Investment Management first reported a position in RCKT in Q4 2023 and held it in 7 quarters. The position peaked at $2.21M in Q2 2024. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • NEOS Investment Management reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • NEOS Investment Management sold 32,030 Rocket Pharmaceuticals shares in Q3 2025, an estimated $78.5K.
  • NEOS Investment Management first reported a position in Rocket Pharmaceuticals in Q4 2023 and held it in 7 quarters.
  • NEOS Investment Management's Rocket Pharmaceuticals position peaked at $2.21M in Q2 2024.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on NEOS Investment Management's 13F filing for Q3 2025, filed 7 Nov 2025.